Does thyroid diseases contribute to the natural history of idiopathic adult-onset dystonia? Data from the Italian Dystonia Registry.

Dystonia Hyperthyroidism Hypothyroidim Thyroid disease

Journal

Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341

Informations de publication

Date de publication:
20 Feb 2024
Historique:
received: 04 01 2024
accepted: 08 02 2024
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 20 2 2024
Statut: aheadofprint

Résumé

A few earlier observations and recent controlled studies pointed to the possible contribution of thyroid diseases in idiopathic adult-onset dystonia (IAOD). The aim of this study was to investigate the association between thyroid status and clinical characteristics of IAOD, focusing on dystonia localization, spread, and associated features such as tremors and sensory tricks. Patients were identified from those included in the Italian Dystonia Registry, a multicentre dataset of patients with adult-onset dystonia. The study population included 1518 IAOD patients. Patients with hypothyroidism and hyperthyroidism were compared with those without any thyroid disease. In the 1518 IAOD patients, 167 patients (11%; 95% CI 9.5-12.6%) were diagnosed with hypothyroidism and 42 (2.8%; 95% CI 1.99-3.74) with hyperthyroidism. The three groups were comparable in age at dystonia onset, but there were more women than men in the groups with thyroid disease. Analysing the anatomical distribution of dystonia, more patients with blepharospasm were present in the hyperthyroidism group, but the difference did not reach statistical significance after the Bonferroni correction. The remaining dystonia-affected body sites were similarly distributed in the three groups, as did dystonia-associated features and spread. Our findings provided novel information indicating that the high rate of thyroid diseases is not specific for any specific dystonia subpopulation and does not appear to influence the natural history of the disease.

Identifiants

pubmed: 38376582
doi: 10.1007/s00702-024-02753-7
pii: 10.1007/s00702-024-02753-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Références

Abbruzzese G, Berardelli A, Girlanda P, Marchese R, Martino D, Morgante F, Avanzino L, Colosimo C, Defazio G (2008) Long-term assessment of the risk of spread in primary late-onset focal dystonia. J Neurol Neurosurg Psychiatry 79(4):392–396. https://doi.org/10.1136/jnnp.2007.124594
doi: 10.1136/jnnp.2007.124594 pubmed: 17635969
Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28(7):863–873. https://doi.org/10.1002/mds.25475
doi: 10.1002/mds.25475 pubmed: 23649720 pmcid: 3729880
Asirvatham AR, Balachandran K, Mahadevan S, Balasubramanian S (2017) Lingual dyskinesia in hyperthyroidism. BMJ Case Reports. https://doi.org/10.1136/bcr-2017-223226
doi: 10.1136/bcr-2017-223226 pubmed: 29222211 pmcid: 5728249
Conte A, Berardelli I, Ferrazzano G, Pasquini M, Berardelli A, Fabbrini G (2016) Non-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbances. Parkinsonism Relat Disord 22(Suppl 1):S111–S114. https://doi.org/10.1016/j.parkreldis.2015.09.001
doi: 10.1016/j.parkreldis.2015.09.001 pubmed: 26360238
Defazio G (2010) The epidemiology of primary dystonia: current evidence and perspectives. Eur J Neurol 17(Suppl 1):9–14. https://doi.org/10.1111/j.1468-1331.2010.03053.x
doi: 10.1111/j.1468-1331.2010.03053.x pubmed: 20590802
Defazio G, Berardelli A (2021) Is adult-onset dystonia a rare disease? time for population-based studies. Mov Disord 36(5):1119–1124. https://doi.org/10.1002/mds.28560
doi: 10.1002/mds.28560 pubmed: 33724530
Defazio G, Berardelli A, Abbruzzese G et al (1998) Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry 64(1):25–32. https://doi.org/10.1136/jnnp.64.1.25
doi: 10.1136/jnnp.64.1.25 pubmed: 9436723 pmcid: 2169915
Defazio G, Conte A, Gigante AF, Fabbrini G, Berardelli A (2015) Is tremor in dystonia a phenotypic feature of dystonia? Neurology 84(10):1053–1059. https://doi.org/10.1212/WNL.0000000000001341
doi: 10.1212/WNL.0000000000001341 pubmed: 25663232
Defazio G, Esposito M, Abbruzzese et al (2017) The Italian Dystonia Registry: rationale, design, and preliminary findings. Neurolgical Sci 38(5):819–825. https://doi.org/10.1007/s10072-017-2839-3
doi: 10.1007/s10072-017-2839-3
Ercoli T, Defazio G, Muroni A (2019) Cerebellar syndrome associated with thyroid disorders. Cerebellum (lond, Engl) 18(5):932–940. https://doi.org/10.1007/s12311-019-01059-9
doi: 10.1007/s12311-019-01059-9
Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC (2014) The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 99(3):923–931. https://doi.org/10.1210/jc.2013-2409
doi: 10.1210/jc.2013-2409 pubmed: 24423323
Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR, Investigators DC (2013) The focal dystonias: current views and challenges for future research. Mov Disord 28(7):926–943. https://doi.org/10.1002/mds.25567
doi: 10.1002/mds.25567 pubmed: 23893450 pmcid: 3733486
Kilic-Berkmen G, Scorr LM, Rosen A, Wu E, Freeman A, Silver M, Hanfelt J, Jinnah HA (2023) Thyroid disease in cervical dystonia. Parkinsonism Relat Disord 107:105274. https://doi.org/10.1016/j.parkreldis.2022.105274
doi: 10.1016/j.parkreldis.2022.105274 pubmed: 36621155
Kravets I (2016) Hyperthyroidism: diagnosis and treatment. Am Fam Physician 93(5):363–370
pubmed: 26926973
Lang AE (1985) Familial Meige syndrome and thyroid dysfunction. Neurology 35(1):138. https://doi.org/10.1212/wnl.35.1.138
doi: 10.1212/wnl.35.1.138 pubmed: 3965992
LeDoux MS (2012) Dystonia: phenomenology. Parkinsonism Relat Disord 18(Suppl 1):S162–S164. https://doi.org/10.1016/S1353-8020(11)70050-5
doi: 10.1016/S1353-8020(11)70050-5 pubmed: 22166421 pmcid: 4869992
Loh LM, Hum AY, Teoh HL, Lim EC (2005) Graves’ disease associated with spasmodic truncal flexion. Parkinsonism Relat Disord 11(2):117–119. https://doi.org/10.1016/j.parkreldis.2004.08.004
doi: 10.1016/j.parkreldis.2004.08.004 pubmed: 15734671
Martino D, Berardelli A, Abbruzzese, et al (2012) Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia. Movement Disorders: Official Journal of the Movement Disorder Society 27(11):1447–1450. https://doi.org/10.1002/mds.25088
doi: 10.1002/mds.25088 pubmed: 22890501
Miranda M, Bustamante ML, Campero M, Wainstein E, Toche P, Espay AJ, Walker RH, Lang AE (2018) Movement disorders in non-encephalopathic Hashimoto’s thyroiditis. Parkinsonism Relat Disord 55:141–142. https://doi.org/10.1016/j.parkreldis.2018.06.008
doi: 10.1016/j.parkreldis.2018.06.008 pubmed: 29887356
Schneider SA, Tschaidse L, Reisch N (2023) Thyroid disorders and movement disorders—a systematic review. Mov Disord Clin Pract 10(3):360–368. https://doi.org/10.1002/mdc3.13656
doi: 10.1002/mdc3.13656 pubmed: 36949803 pmcid: 10026317
Tan EK, Chan LL (2006) Movement disorders associated with hyperthyroidism: expanding the phenotype. Mov Disord 21(7):1054–1055. https://doi.org/10.1002/mds.20883
doi: 10.1002/mds.20883 pubmed: 16615065
Tarsy D, Simon DK (2006) Dystonia. N Engl J Med 355(8):818–829. https://doi.org/10.1056/NEJMra055549
doi: 10.1056/NEJMra055549 pubmed: 16928997
Wiersinga WM (2014) Adult hypothyroidism. In: Feingold KR et al (eds) Endotext. MDText.com Inc

Auteurs

Sarah Idrissi (S)

Department of Translational Biomedicine and Neuroscience (DiBraiN), "Aldo Moro" University of Bari, Bari, Italy. idrissi.sarah2589@gmail.com.

Vittorio Velucci (V)

Department of Translational Biomedicine and Neuroscience (DiBraiN), "Aldo Moro" University of Bari, Bari, Italy.

Marcello Esposito (M)

Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.

Assunta Trinchillo (A)

Department of Neurosciences, Reproductive Sciences and Odontostomatology, Federico II" University, Naples, Italy.
Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.

Francesco Habestwallner (F)

Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.

Daniele Belvisi (D)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
IRCCS Neuromed Institute, Pozzilli, Italy.

Giovanni Fabbrini (G)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
IRCCS Neuromed Institute, Pozzilli, Italy.

Gina Ferrazzano (G)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Vincenzo Rizzo (V)

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Carmen Terranova (C)

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Paolo Girlanda (P)

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Roberta Pellicciari (R)

Department of Translational Biomedicine and Neuroscience (DiBraiN), "Aldo Moro" University of Bari, Bari, Italy.

Laura Avanzino (L)

Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.

Francesca Di Biasio (F)

IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.

Roberta Marchese (R)

IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.

Francesco Bono (F)

Centre for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater Domini, Catanzaro, Italy.

Giovanni Idone (G)

Centre for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater Domini, Catanzaro, Italy.

Vincenzo Laterza (V)

Centre for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater Domini, Catanzaro, Italy.

Christian Lettieri (C)

Clinical Neurology Unit, "S. Maria della Misericordia" University-Hospital, Udine, Italy.

Sara Rinaldo (S)

Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Roberto Eleopra (R)

Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Anna Castagna (A)

IRCCS, Don Carlo Gnocchi Foundation Onlus, Milan, Italy.

Maria Concetta Altavista (MC)

Neurology Unit, San Filippo Neri Hospital ASL Rome, Rome, Italy.

Vincenzo Moschella (V)

Neurology Unit, San Filippo Neri Hospital ASL Rome, Rome, Italy.

Roberto Erro (R)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Paolo Barone (P)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Pierangelo Barbero (P)

Neurology Unit, Mauriziano Umberto I Hospital, Turin, Italy.

Roberto Ceravolo (R)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Sonia Mazzucchi (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Marcello Mario Mascia (MM)

Neurology Unit, University Hospital of Cagliari, Cagliari, Italy.

Tommaso Ercoli (T)

Neurology Unit, University Hospital of Cagliari, Cagliari, Italy.

Antonella Muroni (A)

Neurology Unit, University Hospital of Cagliari, Cagliari, Italy.

Maurizio Zibetti (M)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.

Leonardo Lopiano (L)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.

Cesa Lorella Maria Scaglione (CLM)

IRCCS Institute of Neurological Sciences, Bologna, Italy.

Anna Rita Bentivoglio (AR)

Institute of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.

Martina Petracca (M)

Institute of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.

Luca Magistrelli (L)

Department of Translational Medicine, Movement Disorders Centre, Neurology Unit, University of Eastern Piedmont, Novara, Italy.

Maria Sofia Cotelli (MS)

Neurology Unit, ASST Valcamonica, Esine, Brescia, Italy.

Giovanni Cossu (G)

Neurology Service and Stroke Unit, Department of Neuroscience, AO Brotzu, Cagliari, Italy.

Giovanna Maddalena Squintani (GM)

Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Tiziana De Santis (T)

Department of Neurology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Tommaso Schirinzi (T)

Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Salvatore Misceo (S)

Section of Neurology, San Paolo Hospital, Bari, Italy.

Antonio Pisani (A)

Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Alfredo Berardelli (A)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
IRCCS Neuromed Institute, Pozzilli, Italy.

Giovanni Defazio (G)

Department of Translational Biomedicine and Neuroscience (DiBraiN), "Aldo Moro" University of Bari, Bari, Italy.

Classifications MeSH